254 related articles for article (PubMed ID: 23560298)
1. CD200 upregulation in vascular endothelium surrounding cutaneous squamous cell carcinoma.
Belkin DA; Mitsui H; Wang CQ; Gonzalez J; Zhang S; Shah KR; Coats I; Suàrez-Fariñas M; Krueger JG; Felsen D; Carucci JA
JAMA Dermatol; 2013 Feb; 149(2):178-86. PubMed ID: 23560298
[TBL] [Abstract][Full Text] [Related]
2. The human cutaneous squamous cell carcinoma microenvironment is characterized by increased lymphatic density and enhanced expression of macrophage-derived VEGF-C.
Moussai D; Mitsui H; Pettersen JS; Pierson KC; Shah KR; Suárez-Fariñas M; Cardinale IR; Bluth MJ; Krueger JG; Carucci JA
J Invest Dermatol; 2011 Jan; 131(1):229-36. PubMed ID: 20827282
[TBL] [Abstract][Full Text] [Related]
3. The immunosuppressive surface ligand CD200 augments the metastatic capacity of squamous cell carcinoma.
Stumpfova M; Ratner D; Desciak EB; Eliezri YD; Owens DM
Cancer Res; 2010 Apr; 70(7):2962-72. PubMed ID: 20332223
[TBL] [Abstract][Full Text] [Related]
4. Characterization and functionality of the CD200-CD200R system during mesenchymal stromal cell interactions with T-lymphocytes.
Najar M; Raicevic G; Jebbawi F; De Bruyn C; Meuleman N; Bron D; Toungouz M; Lagneaux L
Immunol Lett; 2012 Aug; 146(1-2):50-6. PubMed ID: 22575528
[TBL] [Abstract][Full Text] [Related]
5. Reduced CD200 and CD200R1 expression in human chorionic villi contributes to early spontaneous abortion.
Wang LQ; Yan CF; Zhao Y; Chu J; Yu XW
Acta Obstet Gynecol Scand; 2014 Dec; 93(12):1248-54. PubMed ID: 25145957
[TBL] [Abstract][Full Text] [Related]
6. The CD200-CD200R Axis Promotes Squamous Cell Carcinoma Metastasis via Regulation of Cathepsin K.
Khan IZ; Del Guzzo CA; Shao A; Cho J; Du R; Cohen AO; Owens DM
Cancer Res; 2021 Oct; 81(19):5021-5032. PubMed ID: 34183355
[TBL] [Abstract][Full Text] [Related]
7. The role of CD200-CD200R in tumor immune evasion.
Liao KL; Bai XF; Friedman A
J Theor Biol; 2013 Jul; 328():65-76. PubMed ID: 23541619
[TBL] [Abstract][Full Text] [Related]
8. CD200-CD200R signaling suppresses anti-tumor responses independently of CD200 expression on the tumor.
Rygiel TP; Karnam G; Goverse G; van der Marel AP; Greuter MJ; van Schaarenburg RA; Visser WF; Brenkman AB; Molenaar R; Hoek RM; Mebius RE; Meyaard L
Oncogene; 2012 Jun; 31(24):2979-88. PubMed ID: 22020332
[TBL] [Abstract][Full Text] [Related]
9. Decreased expression of CD200 and CD200 receptor in Alzheimer's disease: a potential mechanism leading to chronic inflammation.
Walker DG; Dalsing-Hernandez JE; Campbell NA; Lue LF
Exp Neurol; 2009 Jan; 215(1):5-19. PubMed ID: 18938162
[TBL] [Abstract][Full Text] [Related]
10. Gene expression patterns of normal human skin, actinic keratosis, and squamous cell carcinoma: a spectrum of disease progression.
Padilla RS; Sebastian S; Jiang Z; Nindl I; Larson R
Arch Dermatol; 2010 Mar; 146(3):288-93. PubMed ID: 20231500
[TBL] [Abstract][Full Text] [Related]
11. The expressions of CD200 and CD200R molecules on myeloid and lymphoid dendritic cells in pre-eclampsia and normal pregnancy.
Darmochwal-Kolarz DA; Kludka-Sternik M; Chmielewski T; Kolarz B; Rolinski J; Leszczynska-Gorzelak B; Oleszczuk J
Am J Reprod Immunol; 2012 Jun; 67(6):474-81. PubMed ID: 22462561
[TBL] [Abstract][Full Text] [Related]
12. Tenascin-C patterns and splice variants in actinic keratosis and cutaneous squamous cell carcinoma.
Dang C; Gottschling M; Roewert J; Forschner T; Stockfleth E; Nindl I
Br J Dermatol; 2006 Oct; 155(4):763-70. PubMed ID: 16965426
[TBL] [Abstract][Full Text] [Related]
13. [CD200/CD200R Expression Levels and Its Significance after Allogeneic Hematopoietic Stem Cell Transplantation].
Huang YH; Zhang W; Cai H; Li TJ; Li J; Han B; Zhuang JL; Zhu TN; Cai HC; Zhou DB
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Jun; 24(3):815-20. PubMed ID: 27342516
[TBL] [Abstract][Full Text] [Related]
14. CD200-CD200R Pathway in the Regulation of Tumor Immune Microenvironment and Immunotherapy.
Liu JQ; Hu A; Zhu J; Yu J; Talebian F; Bai XF
Adv Exp Med Biol; 2020; 1223():155-165. PubMed ID: 32030689
[TBL] [Abstract][Full Text] [Related]
15. Immunosuppression affects CD4+ mRNA expression and induces Th2 dominance in the microenvironment of cutaneous squamous cell carcinoma in organ transplant recipients.
Kosmidis M; Dziunycz P; Suárez-Fariñas M; Mühleisen B; Schärer L; Läuchli S; Hafner J; French LE; Schmidt-Weber C; Carucci JA; Hofbauer GF
J Immunother; 2010 Jun; 33(5):538-46. PubMed ID: 20463594
[TBL] [Abstract][Full Text] [Related]
16. T-cadherin loss promotes experimental metastasis of squamous cell carcinoma.
Philippova M; Pfaff D; Kyriakakis E; Buechner SA; Iezzi G; Spagnoli GC; Schoenenberger AW; Erne P; Resink TJ
Eur J Cancer; 2013 May; 49(8):2048-58. PubMed ID: 23369463
[TBL] [Abstract][Full Text] [Related]
17. CCR10 and CCL27 are overexpressed in cutaneous squamous cell carcinoma.
Kai H; Kadono T; Kakinuma T; Tomita M; Ohmatsu H; Asano Y; Tada Y; Sugaya M; Sato S
Pathol Res Pract; 2011 Jan; 207(1):43-8. PubMed ID: 21144674
[TBL] [Abstract][Full Text] [Related]
18. CD200R, a co-inhibitory receptor on immune cells, predicts the prognosis of human hepatocellular carcinoma.
Sun H; Xu J; Huang M; Huang Q; Sun R; Xiao W; Sun C
Immunol Lett; 2016 Oct; 178():105-13. PubMed ID: 27562325
[TBL] [Abstract][Full Text] [Related]
19. Expression of CD200 and CD200R regulatory molecules on the CD83+ monocyte-derived dendritic cells generated from patients with laryngeal cancer.
Klatka J; Grywalska E; Klatka M; Rahnama M; Polak A; Rolinski J
Folia Histochem Cytobiol; 2013; 51(1):59-65. PubMed ID: 23690219
[TBL] [Abstract][Full Text] [Related]
20. The immune inhibitory complex CD200/CD200R is developmentally regulated in the mouse brain.
Shrivastava K; Gonzalez P; Acarin L
J Comp Neurol; 2012 Aug; 520(12):2657-75. PubMed ID: 22323214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]